Lawson Health Research Institute, Parkwood Research Institute, Parkwood Institute, London, Ontario, Canada.
St. Joseph's Health Care, Parkwood Institute, London, Ontario, Canada.
Top Stroke Rehabil. 2023 May;30(4):368-383. doi: 10.1080/10749357.2022.2049505. Epub 2022 Mar 30.
Post-stroke anxiety and depression can be disabling and result in impaired recovery. Cognitive-behavioral therapy (CBT) has been demonstrated to be effective for anxiety and depression; however, determining its efficacy among those with stroke is warranted. Our objectives to evaluate CBT for anxiety and depression post-stroke .
This review was registered with PROSPERO (REG# CRD42020186324). Medline, PsycInfo, and EMBR Cochrane were used to locate studies published before May 2020, using keywords such as stroke and CBT. A study was included if: (1) interventions were CBT-based, targeting anxiety and/or depression; (2) participants experienced a stroke at least 3 months previous; (3) participants were at least 18 years old. Standardized mean differences ± standard errors and 95% confidence intervals were calculated, and heterogeneity was determined. The Cochrane Risk of Bias tool was used.
The search yielded 563 articles, of which 10 ( = 672) were included;6 were randomized controlled trials. Primary reasons for exclusion included: (1) wrong population (2) insufficient data provided for a meta-analysis; (3) wrongoutcomes. CBT showed large effects on reducing overall anxiety (SMD ± SE: 1.01 ± 0.32, < .001) and depression (SMD ± SE: 0.95 ± 0.22, < .000) symptoms at the end of the studies. CBT moderately maintained anxiety (SDM ± SE: 0.779 ± 0.348, ˂.025) and depression (SDM ± SE: 0.622 ± 0.285, ˂ .029) scores after 3-months. Limitations included small sample size, limited comparators, and lack of follow-up data.
The results of this meta-analysis provide substantial evidence for the use of CBTto manage post-stroke anxiety and depression.
中风后焦虑和抑郁可能导致身体残疾,并影响康复。认知行为疗法(CBT)已被证明对焦虑和抑郁有效;然而,确定其在中风患者中的疗效是有必要的。我们的目的是评估 CBT 在中风后治疗焦虑和抑郁的效果。
本综述已在 PROSPERO(注册号:CRD42020186324)上注册。使用 Medline、PsycInfo 和 EMBR Cochrane 数据库,使用“stroke”和“CBT”等关键词搜索 2020 年 5 月前发表的研究。如果符合以下标准,则纳入研究:(1)干预措施基于 CBT,针对焦虑和/或抑郁;(2)参与者在至少 3 个月前经历过中风;(3)参与者年龄至少为 18 岁。计算标准化均数差(SMD)±标准误差(SE)和 95%置信区间,并确定异质性。使用 Cochrane 偏倚风险工具评估研究质量。
搜索结果共 563 篇文章,其中 10 篇( = 672 名参与者)符合纳入标准;其中 6 篇为随机对照试验。排除的主要原因包括:(1)错误的研究人群;(2)提供的数据不足以进行荟萃分析;(3)错误的结局指标。CBT 在研究结束时显示出对降低总体焦虑(SMD ± SE:1.01 ± 0.32, <.001)和抑郁(SMD ± SE:0.95 ± 0.22, <.000)症状有显著效果。CBT 在 3 个月后对焦虑(SDM ± SE:0.779 ± 0.348, ˂.025)和抑郁(SDM ± SE:0.622 ± 0.285, ˂.029)评分的维持效果适中。局限性包括样本量小、对照有限和缺乏随访数据。
这项荟萃分析的结果为使用 CBT 治疗中风后焦虑和抑郁提供了充分的证据。